Participation

Annual General Meeting of Sandvik Aktiebolag

Retrieved on: 
Wednesday, March 20, 2024
Malpractice, EPS, Marketing, Remuneration, Audit committee, Annual, Employment, Committee, Malus, Annual general meeting, Kungsbron, Earnings per share, Report, Person, PwC, Social Security, Acquisition, Meeting, Annual report, International business, Auditor, Participation, Growth, LTI, G4, Mass meeting, Management

The Nomination Committee proposes, pursuant to the recommendation of the Audit Committee, re-election of PricewaterhouseCoopers AB as Auditor for the period until the end of the 2025 Annual General Meeting.

Key Points: 
  • The Nomination Committee proposes, pursuant to the recommendation of the Audit Committee, re-election of PricewaterhouseCoopers AB as Auditor for the period until the end of the 2025 Annual General Meeting.
  • The Board of Directors proposes that the Annual General Meeting resolve to adopt the following guidelines for the remuneration of senior executives.
  • The Board of Directors proposes that the Annual General Meeting authorizes the Board of Directors to, for the period until the 2025 Annual General Meeting, resolve on acquisitions of the Company's own shares in accordance with the following conditions.
  • The authorization may be utilized on one or several occasions up to the 2025 Annual General Meeting.

HuLoop Wins ICBA ThinkTECH Accelerator MVP Award, Bankers Choice Award

Retrieved on: 
Saturday, March 16, 2024
Automation, Participation, MVP, Bank, Cognitive computer, FLA, Independent, ICBA, AI, Fiserv, Accelerator, Most, AP6, Data management, Medical device

AUBURN, Calif., March 16, 2024 /PRNewswire/ -- HuLoop Automation (HuLoop), an emerging AI-based intelligent automation software leader, was recognized by the Independent Community Bankers of America (ICBA) during its ThinkTECH Showcase at ICBA LIVE in Orlando Fla. HuLoop, a participant in ICBA's award-winning ThinkTECH Accelerator program was named Most Valuable Participant (MVP) and also selected as this year's Banker's Choice recipient.

Key Points: 
  • AUBURN, Calif., March 16, 2024 /PRNewswire/ -- HuLoop Automation (HuLoop), an emerging AI-based intelligent automation software leader, was recognized by the Independent Community Bankers of America (ICBA) during its ThinkTECH Showcase at ICBA LIVE in Orlando Fla. HuLoop, a participant in ICBA's award-winning ThinkTECH Accelerator program was named Most Valuable Participant (MVP) and also selected as this year's Banker's Choice recipient.
  • The MVP award, sponsored by TrueNorth, recognizes the most-evolved fintech offering based on program engagement and alignment with community bank business priorities.
  • The Banker's Choice Award, sponsored by Fiserv, is selected by an audience vote during the ICBA ThinkTECH Showcase following seven-minute pitches from member of its latest cohort (AP6).
  • "HuLoop is grateful to receive both the MVP and Banker's Choice awards as recognition for the invaluable feedback we received through the ICBA ThinkTECH Accelerator program and its dedication to developing solutions that truly help community banks thrive," HuLoop President and CEO Todd Michaud said.

Trialbee's Jamie Goldfarb to Lead Discussion on Defining Success and Enhancing Collaboration in Clinical Trials at Patients as Partners in Clinical Research Conference

Retrieved on: 
Thursday, March 14, 2024
Honey, Goldfarb, Patient, Success, Partner, Food and Drug Administration, ROI, Digital, TIL, Pharmacy, GSK, Research, Participation, National Cancer Institute, Cancer, Medidata Solutions, Ecosystem, Melanoma, Food, FDA, Process optimization, Fireside chats, Pharmaceutical industry

CHAPEL HILL, N.C. and MALMÖ, Sweden, March 14, 2024 /PRNewswire-PRWeb/ -- Trialbee, the global leader in technology-driven patient recruitment for clinical trials, is honored that Director of Patient Recruitment Strategy Jamie Goldfarb will take center stage at the Patients as Partners in Clinical Research on March 20-22, in Philadelphia, PA.

Key Points: 
  • The session aims to strengthen relationships among sites, sponsors, and patients to deepen understanding and engagement.
  • "Many patients aren't aware that clinical trials present viable treatment opportunities, and if they do, their needs are often overlooked," Goldfarb said.
  • "By actively listening to patients, sponsors can gain invaluable insights and perspectives that lead to medical advances and improve countless lives."
  • The Patients as Partners in Clinical Research conference offers a unique opportunity to hear from pharmaceutical research and development leaders, Food and Drug Administration (FDA) representatives, and patient advocates on how patient involvement drives greater efficiencies in clinical research.

JLL Income Property Trust Announces Q4 2023 Earnings Call

Retrieved on: 
Wednesday, March 13, 2024
Health, Participation, NAV, Trust, Real estate

The audio replay will be posted to the SEC Filings section of the JLL Income Property Trust website at www.jllipt.com within 24 hours of the call.

Key Points: 
  • The audio replay will be posted to the SEC Filings section of the JLL Income Property Trust website at www.jllipt.com within 24 hours of the call.
  • JLL Income Property Trust is an institutionally managed, daily NAV REIT that gives investors access to a growing portfolio of private, core real estate investments selected by an institutional investment management team and sponsored by one of the world's leading real estate services firms.
  • JLL Income Property Trust, Inc. is a daily NAV REIT that owns and manages a diversified portfolio of high quality, income-producing residential, industrial, grocery-anchored retail, healthcare and office properties located in the United States.
  • JLL Income Property Trust expects to further diversify its real estate portfolio over time, including on a global basis.

Majority of People Worldwide Believe in Angels, 36% Had Angelic Encounters, Study Finds

Retrieved on: 
Tuesday, March 12, 2024
NDE, Participation, Perfume, Data, Angel, Research, Face, Prevalence, Skin, Flower, Feather, Nightclub

ATLANTA, March 12, 2024 /PRNewswire/ -- A global study has revealed people's belief in the existence of angels as well as the types of angelic encounters among believers. It included 800 participants from countries such as the United States, United Kingdom, South Africa, and India and found that 75% of its respondents reported a belief in angels. In addition, research showed that 36% of those who believe in angels also claim to have had experiences with these celestial beings, indicating that angelic occurrences are common.

Key Points: 
  • ATLANTA, March 12, 2024 /PRNewswire/ -- A global study has revealed people's belief in the existence of angels as well as the types of angelic encounters among believers.
  • In addition, research showed that 36% of those who believe in angels also claim to have had experiences with these celestial beings, indicating that angelic occurrences are common.
  • Global study reveals 75% of its respondents believe in angels and of those, 36% claim to have had experiences angels.
  • Participant demographics were evenly split between females and males, with the majority falling within the age range of 18 to 40 years.

Inhibikase Therapeutics to Provide Trial Update for Risvodetinib at the 2024 International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders

Retrieved on: 
Thursday, March 7, 2024
Therapy, EDT, Participation, Parkinson's disease, GI, Patient, Symposium, Dementia, Pharmaceutical industry

“Parkinson’s disease remains one of the most prevalent neurodegenerative diseases worldwide, affecting more than a million people in the U.S. alone.

Key Points: 
  • “Parkinson’s disease remains one of the most prevalent neurodegenerative diseases worldwide, affecting more than a million people in the U.S. alone.
  • The 201 Trial evaluating three doses of risvodetinib in untreated Parkinson’s patients is beginning to yield information about the experience of participants on risvodetinib,” said Dr. Werner.
  • Ten mild and one moderate adverse event that might be related to treatment have been reported across all study participants.
  • Depending on the date of enrollment of the last participant, top line results from the 201 Trial might be reported in the second-half of 2024.

Traders Fair Singapore Returns for an Unforgettable Financial Event

Retrieved on: 
Friday, February 23, 2024
Participation, Software, Tourism

Singapore , Feb. 23, 2024 (GLOBE NEWSWIRE) -- Traders Fair, one of the largest and most prestigious financial events globally, is set to make a triumphant return to Singapore.

Key Points: 
  • Singapore , Feb. 23, 2024 (GLOBE NEWSWIRE) -- Traders Fair, one of the largest and most prestigious financial events globally, is set to make a triumphant return to Singapore.
  • Traders Fair Singapore is scheduled to take place on 02/02/2024 at Marina Bay Sans Convention Center.
  • Why Attend Traders Fair Singapore:
    Traders Fair Singapore offers a unique platform for traders, investors, and financial enthusiasts to:
    • Gain valuable knowledge and insights from industry experts.
  • To secure your spot and learn more about the event agenda, exhibitors, speakers, and special offers, please visit Traders Fair Singapore website .

Ocean Capital Calls on Shareholders to Demand Accountability at UBS-Managed Puerto Rico Closed-End Funds

Retrieved on: 
Tuesday, March 5, 2024
Professional Services, Finance, Schedule 13D, Opinion, Recommendation, Participation, Partial, Judgement, UBS, BLUE, CARD, Annual general meeting, OCEAN, Fund, Report, Security (finance), TFF

In addition to electing Ocean Capital’s nominees, Ocean Capital has submitted a business proposal to terminate the investment advisory agreements with UBS at both of these upcoming annual meetings.

Key Points: 
  • In addition to electing Ocean Capital’s nominees, Ocean Capital has submitted a business proposal to terminate the investment advisory agreements with UBS at both of these upcoming annual meetings.
  • Ocean Capital will continue to do everything in its power to compel UBS and its affiliates to respect the will of shareholders.
  • VISIT WWW.IMPROVEUBSPRFUNDS.COM TO LEARN MORE ABOUT OCEAN CAPITAL’S CAMPAIGNS FOR VALUE-ENHANCING CHANGE AT THE FUNDS.
  • 2 The nine Funds include: Tax-Free Fixed Income Fund for Puerto Rico Residents, Inc. (“Fund I”), Tax-Free Fixed Income Fund II for Puerto Rico Residents, Inc. (“Fund II”), Tax-Free Fixed Income Fund III for Puerto Rico Residents, Inc. (“Fund III”), Tax-Free Fixed Income Fund IV for Puerto Rico Residents, Inc. (“Fund IV”), Tax-Free Fixed Income Fund V for Puerto Rico Residents, Inc. (“Fund V”), Puerto Rico Residents Tax-Free Fund, Inc. (“PRITF I”), Puerto Rico Residents Tax-Free Fund IV, Inc (“PRITF IV”), Puerto Rico Residents Tax-Free Fund VI, Inc. (“PRITF VI”) and Tax-Free Fund for Puerto Rico Residents (“TFF I”).

Strategic Organizing Center Issues Statement on ISS Recommendation

Retrieved on: 
Friday, March 1, 2024
Retail, Professional Services, Food, Beverage, Finance, Annual general meeting, Proxy, Starbucks, Participation, BLUE, Nature, Government, Workers United, ISS, Strategic Organizing Center, Annual, SOC, SBUX, Management

The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today commented on the recent report published by Institutional Shareholder Services Inc. (“ISS”) in relation to Starbucks’ upcoming Annual Meeting of Shareholders (the “Annual Meeting”).

Key Points: 
  • The Strategic Organizing Center (the “SOC”), a shareholder of Starbucks Corporation (Nasdaq: SBUX) (“Starbucks” or the “Company”), today commented on the recent report published by Institutional Shareholder Services Inc. (“ISS”) in relation to Starbucks’ upcoming Annual Meeting of Shareholders (the “Annual Meeting”).
  • “While ISS acknowledged the validity of a number of our arguments in its report, we disagree with the view that board change is not currently needed at Starbucks.
  • ISS also concurs that shareholders should be concerned by Starbucks’ share price performance since unionization efforts began.
  • Further, we agree with ISS that the recent announcement of Starbucks and Workers United committing to a path forward is meaningful progress.

FREYR Battery Reports Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Thursday, February 29, 2024
Batteries, Other Manufacturing, Alternative Energy, EV, Electric Vehicles, Energy, Automotive, Technology, Manufacturing, Electrode, Battery, Participation, New York Stock Exchange, Investment, Quasi-solid, NMC, LFP, Central European, Automation, Map, Casting, DOE, Kilowatt-hour, Research, Software

FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the fourth quarter and full year of 2023.

Key Points: 
  • FREYR Battery, Inc. (NYSE: FREY) (“FREYR” or the “Company”), a developer of clean, next-generation battery cell production capacity, today reported financial results for the fourth quarter and full year of 2023.
  • FREYR expects to commence production of functional battery cells for customer samples using the full automation of the CQP in H1 2024.
  • FREYR reported net loss attributable to stockholders for the fourth quarter of 2023 of $(24.2) million, or $(0.17) per diluted share compared to net income for the fourth quarter 2022 of $25.3 million or $0.20 per diluted share.
  • A presentation will be held today, February 29, 2024, at 8:30 am Eastern Standard Time (2:30 pm Central European Time) to discuss financial results for the fourth quarter and full year 2023.